DDN Dialogues
Inactivesciencelife

DDN Dialogues

by Drug Discovery News

Is this your podcast?

Insights from recent episode analysis

Audience Interest

Estimated Reach: 101K to 303K
Listeners across platforms

Podcast Focus

Categories: science · life

Publishing Consistency

Frequency: ~Weekly
11 episodes since 2023

Platform Reach

Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.

Medium Confidence

Total monthly reach

101K to 303K

Estimated from 2 chart positions in 2 markets.

By chart position

  • 🇦🇺
    AU · Life Sciences
    #34
    100K to 300K
  • 🇧🇪
    BE · Life Sciences
    #124
    500 to 3K
  • Per-Episode Audience

    Est. listeners per new episode within ~30 days

    50K to 152K
    🎙 Weekly cadence·11 episodes·Long inactive
  • Monthly Reach

    Unique listeners across all episodes (30 days)

    101K to 303K
    🇦🇺99%🇧🇪1%
  • Active Followers

    Loyal subscribers who consistently listen

    30K to 91K

Market Insights

This ShowCategory Avg
No category insights available.
📡

Platform Distribution

Reach across major podcast platforms, updated hourly

Total Followers

Total Plays

Total Reviews

YouTube

YouTube

Subscribers

Views

Videos

Castbox

Castbox

Followers

Plays

Reviews

Podcast App

Podcast App

Followers

Plays

Reviews

Podcast Republic

Podcast Republic

Followers

Plays

Reviews

TuneIn

TuneIn

Followers

Plays

Reviews

* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.

On the show

Recent episodes

Seeing into the future of autism detection

Sep 18, 2024

15m 37s

Healing a broken heart

Aug 14, 2024

18m 05s

The antibiotics hidden in medieval recipes

Jul 3, 2024

25m 38s

Rejuvenating the retina to save vision

May 29, 2024

15m 07s

From warhead to cancer-killer, the quest for more actinium-225

May 8, 2024

28m 52s

🔗

Social Links & Contact

Official channels & resources

🌐

Official Website

Login

📡

RSS Feed

Login

Chart Positions

2 placements across 2 markets.